These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 18004205)

  • 1. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
    Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL
    Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence.
    Swan GE; Benowitz NL; Lessov CN; Jacob P; Tyndale RF; Wilhelmsen K
    Pharmacogenet Genomics; 2005 Feb; 15(2):115-25. PubMed ID: 15861035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics.
    Al Koudsi N; Mwenifumbo JC; Sellers EM; Benowitz NL; Swan GE; Tyndale RF
    Eur J Clin Pharmacol; 2006 Jun; 62(6):481-4. PubMed ID: 16758265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
    Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
    Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people.
    Binnington MJ; Zhu AZ; Renner CC; Lanier AP; Hatsukami DK; Benowitz NL; Tyndale RF
    Pharmacogenet Genomics; 2012 Jun; 22(6):429-40. PubMed ID: 22569203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of single nucleotide polymorphisms with amino acid substitution in CYP1A2, CYP2A6, and CYP2B6 found in the Japanese population.
    Iwasaki M; Yoshimura Y; Asahi S; Saito K; Sakai S; Morita S; Takenaka O; Inoda T; Kashiyama E; Aoyama A; Nakabayashi T; Omori S; Kuwabara T; Izumi T; Nakamura K; Takanaka K; Nakayama Y; Takeuchi M; Nakamura H; Kametani S; Terauchi Y; Hashizume T; Nagayama S; Kume T; Achira M; Kawai H; Kawashiro T; Nakamura A; Nakai Y; Kagayama A; Shiraga T; Niwa T; Yoshimura T; Morita J; Ohsawa F; Tani M; Osawa N; Ida K; Noguchi K
    Drug Metab Pharmacokinet; 2004 Dec; 19(6):444-52. PubMed ID: 15681899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
    Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.
    Lee AM; Jepson C; Hoffmann E; Epstein L; Hawk LW; Lerman C; Tyndale RF
    Biol Psychiatry; 2007 Sep; 62(6):635-41. PubMed ID: 17223085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.
    Kiang TK; Ho PC; Anari MR; Tong V; Abbott FS; Chang TK
    Toxicol Sci; 2006 Dec; 94(2):261-71. PubMed ID: 16945988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of nicotine treatment and ethanol self-administration on CYP2A6, CYP2B6 and nicotine pharmacokinetics in African green monkeys.
    Ferguson CS; Miksys S; Palmour RM; Tyndale RF
    J Pharmacol Exp Ther; 2012 Dec; 343(3):628-37. PubMed ID: 22935730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions.
    Yamanaka H; Nakajima M; Fukami T; Sakai H; Nakamura A; Katoh M; Takamiya M; Aoki Y; Yokoi T
    Drug Metab Dispos; 2005 Dec; 33(12):1811-8. PubMed ID: 16135656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.
    Nakajima M; Kuroiwa Y; Yokoi T
    Drug Metab Rev; 2002 Nov; 34(4):865-77. PubMed ID: 12487152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
    Dempsey D; Tutka P; Jacob P; Allen F; Schoedel K; Tyndale RF; Benowitz NL
    Clin Pharmacol Ther; 2004 Jul; 76(1):64-72. PubMed ID: 15229465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation.
    Nakajima M; Yokoi T
    Drug Metab Pharmacokinet; 2005 Aug; 20(4):227-35. PubMed ID: 16141602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
    Nakajima M; Fukami T; Yamanaka H; Higashi E; Sakai H; Yoshida R; Kwon JT; McLeod HL; Yokoi T
    Clin Pharmacol Ther; 2006 Sep; 80(3):282-97. PubMed ID: 16952495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.
    Mwenifumbo JC; Lessov-Schlaggar CN; Zhou Q; Krasnow RE; Swan GE; Benowitz NL; Tyndale RF
    Clin Pharmacol Ther; 2008 Jan; 83(1):115-21. PubMed ID: 17522595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.
    Mwenifumbo JC; Tyndale RF
    Pharmacogenomics; 2007 Oct; 8(10):1385-402. PubMed ID: 17979512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
    Nakajima M
    Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine.
    Swan GE; Lessov-Schlaggar CN; Bergen AW; He Y; Tyndale RF; Benowitz NL
    Pharmacogenet Genomics; 2009 May; 19(5):388-98. PubMed ID: 19300303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.